Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2358 of 6351
-
New cancer drug HLX42 enters first human trial
Disease control Recruiting nowThis study is an open-label first-in-human phase I clinical study to evaluate the safety and tolerability of HLX42.
Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Glowing dye could help surgeons remove sarcomas in one go
Diagnosis Recruiting nowThis study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Mailed test kits aim to boost colon cancer screening in underserved brooklyn
Prevention By invitation onlyThe purpose of the study is to boost colorectal cancer (CRC) screening rates in an underserved population in Brooklyn through organized, proactive outreach of mailed Fecal Immunochemical Tests (FIT), utilizing evidence-based interventions tailored to the needs of the population.
Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Could this sleep drug help Alzheimer's patients rest better?
Symptom relief Recruiting nowDARIDOR-ALZ is a phase IV clinical trial designed to evaluate both the efficacy and safety of daridorexant, a selective dual orexin receptor antagonist that blocks the actions of the orexin neuropeptides at both orexin-1 and orexin-2 receptors, in selected populations of MCI and …
Phase 4 • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to tackle tough blood cancer
Disease control Recruiting nowSystemic mastocytosis with an associated hematologic neoplasm (SM-AHN) is a challenging disease to treat. Targeted KIT inhibitors have been approved for this indication based on their ability to control the mastocytosis portion of the disease, but patients frequently experience p…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Virtual clinic aims to reverse 'ICU Brain' in survivors of critical illness
Disease control Recruiting nowIntact cognitive skills are necessary for independent living, going to work, and managing finances, and any loss of cognitive skills places a burden on society akin to what is seen with Alzheimer's Disease and Related Dementias. The TelePORT Study (Telehealth-Enhanced Patient-Ori…
Sponsor: Vanderbilt University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could your smartphone detect a heart attack? new study aims to find out.
Diagnosis Recruiting nowAliveCor (www.alivecor.com) has developed several electrocardiogram (ECG) devices that interface with iOS and Android smartphones and tablets via various Kardia apps. The current Kardia family of devices can measure single lead and six limb-lead ECGs, depending on the device. Kar…
Sponsor: AliveCor • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Can a cancer drug shrink tumors in men with a key gene loss?
Disease control OngoingThe goal of this clinical trial is to test the anti-tumor activity of bortezomib in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC) with PTEN Deletion. The main question\[s\] it aims to answer is if the use of bortezomib will result in a decline in PSA …
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a heart drug ease long COVID symptoms?
Symptom relief CompletedThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This protocol is a prospective, mu…
Phase 2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Swiss study tests if pharmacy cannabis reduces smoking risks
Disease control OngoingThough regulated cannabis sales are increasing, little is known about the individual health effects of cannabis regulation. Data from countries with a regulated market can be used to test the effect of regulation on the price of cannabis in the illicit market, and to explore its …
Sponsor: University of Bern • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New DNA test could speed up bone infection diagnosis
Diagnosis CompletedThe value of next-generation sequencing (NGS) using Nanopore technology has been demonstrated in the case of diabetic patients' wounds or in prosthetic joint infections. The aim of this study is to demonstrate its relevance as a new diagnostic approach for fracture-related infect…
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Massive registry launches to track heart ablation outcomes
Disease control Recruiting nowThe primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Sponsor: AtriCure, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Which antibiotic works best when water breaks early?
Disease control OngoingThe goal of this study is to help identify the best antibiotic treatment for pregnant people when their water breaks prematurely (a condition abbreviated as PPROM). Current practice is to attempt to maintain the pregnancy until at least 34 weeks gestational age, when the risks of…
Phase 3 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Liver probe reveals secrets of hepatitis b persistence
Knowledge-focused Recruiting nowTwo hundred and ninety-six million people worldwide are chronically infected with the hepatitis B virus (HBV), with around 750,000 deaths each year linked to the development of cirrhosis or hepatocellular carcinoma. Current treatments based on nucleoside analogues (NA) achieve vi…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Simple video may boost ovarian cancer prevention during other surgeries
Prevention Recruiting nowThe purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Smart implant adjusts itself to fight chronic pain
Symptom relief OngoingThe purpose of this study is to evaluate the clinical utility of neurophysiological measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide treatment of chronic pain of the trunk and/or limbs.
Sponsor: Saluda Medical Pty Ltd • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Which therapy works best for teens with eating disorders? new study aims to find out
Symptom relief Recruiting nowThe goal of this randomized controlled clinical trial is to compare the efficacy of outpatient family-based treatment versus enhanced cognitive behavior therapy for children and adolescents with eating disorders. Because of insufficient recruitment, the study design was modified…
Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Sound waves vs. scalpel: new study tests shockwave therapy for blocked leg arteries
Disease control OngoingThe investigators hypothesize that Shockwave with DCB is non-inferior to surgical endarterectomy for common femoral artery (CFA) stenosis with regard to primary efficacy and safety endpoints. The study will challenge the current guideline that recommends common femoral endarterec…
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart vibration tech could spot aortic disease without scans
Diagnosis Recruiting nowKinocardiography (KCG) is a portable measurement technique developed to estimate cardiac mechanical performance by studying the vibrations produced by myocardial contraction during each heartbeat and transmitted to the body surface. The goal of this observational study is to lea…
Sponsor: Université Libre de Bruxelles • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New heart valve trial aims to improve treatment for severe aortic stenosis
Disease control OngoingThe objective of this study is to evaluate the ACURATE Neo2 in the Middle East population with severe, symptomatic aortic stenosis.
Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC